As of 2026-06-15, the Fair Value of Crinetics Pharmaceuticals Inc (CRNX) is -23.54 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 35.12 USD, the upside of Crinetics Pharmaceuticals Inc is -167.02%.
With the market price of 35.12 USD and our fair value calculation, Crinetics Pharmaceuticals Inc (CRNX) is not a good investment. Investing in CRNX stocks now will result in a potential loss of 167.02%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -107.64 | -163.92 | -214.53 | -298.41 | -465.32 | -249.96 |
| YoY growth | -45.83% | -52.29% | -30.87% | -39.10% | -55.93% | -44.81% |
| Market Cap (mil) | 3,703.05 |
| P/E | |
| Forward P/E |
| EPS | -4.71 |
| Avg earnings growth rate | -44.81% |
| TTM earnings | -496.39 |